|
Digital therapeutics - the increasing regulatory support has facilitated the establishment of a standard developmental pathway for these solutions
Digital therapeutics are clinically validated applications / software / online programs that have demonstrated the capability to facilitate positive outcomes when used in the prevention / treatment / management of diseases / clinical conditions. These therapeutics are designed to engage patients in personalized treatment or disease prevention programs, through mediating behavioral or psychological modifications, providing motivational support and inculcating healthy lifestyle changes.
The global digital therapeutics market size is estimated to grow from USD 2.83 billion in 2024 to USD 19.76 billion by 2035, representing a CAGR of 19.32% during the forecast period till 2035.
Several organizations have undertaken diverse initiatives in the field of digital therapeutics to support its growth as a new frontier in the healthcare sector. A number of organizations focused on effectively monitoring and promoting the potential of digital therapeutics to be used as a part of strategies to improve the population health have also been established. These organizations include:
- Digital Therapeutics Alliance (DTA)
- Personal Connected Health (PCH) Alliance
- Centers for Disease Control and Prevention (CDC)
- Health Insurance Portability and Accountability Act (HIPAA)
- National Health Service (NHS)
- United States Food and Drug Administration (USFDA)
Browse for more related reports
https://bn.parinux.org/p/r.a27c9c785b821b0c3b4e380231ff069d
https://pad.opportunis.me/p/r.0a1708fe9a94cf098fcf5158bf010aa8
https://pad.freeshell.de/p/r.e9da0890b32de4f24764d50848f21956
https://pad.piratensommer.de/p/r.ff9634dad90d48f29d86f6352fae392e
https://etherpad.p2pu.org/p/r.9ee59676a830967cd22743f1307424b2
https://pad.liberta.vip/p/r.db624517c85ace5fe4b0cb3c2608ad80
https://cryptpad.uni-due.de/p/r.a0225537bc973f2a98b0a71228f6e271
https://sara-etherpad.swedencentral.cloudapp.azure.com/p/r.3da0e0f0e1a559b0b317d46737ba2225
https://etherpad.mit.edu/p/r.9a40b393e6cad0f02beeeb9535d244f4
https://etherpad.servus.at/p/r.e14c62b591334078ef1ffe985caf9fcf
https://etherpad.osuosl.org/p/r.bb1aa4ec33af917af7cbdc6b5764979f
https://wabe-etherpad.takuma.de/p/r.71b807829fa85aed99b221df87730939
https://pad.bluematt.me/p/r.9a2fcaafb00c960aa55c4f04773c5baf
https://etherpad.greylightprojects.org/p/r.af9dff29b85ad190839562c51d53fdd1
https://etherpad.indieweb.org/p/r.6c404aebd43be5eb720452ba0720ad89
https://pad.interior.edu.uy/p/r.e754985b2d7deeb7d9c3bd589b6e65ff
https://etherpad.f-si.org/p/r.5738e10d3d10f1a9c49a379b679a5f96
https://pad.xes.cat/p/r.de84a5d065bc128ad4d6673695584a06
https://etherpad.uos.de/p/r.46e247008e83ea06b5fa2e93c8bd112f
https://etherpad.uni-duisburg-essen.de/p/r.a0225537bc973f2a98b0a71228f6e271
|
